Singapore, Singapore

Anis Larbi

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Anis Larbi: Innovator in Infectious Disease Evaluation

Introduction

Anis Larbi is a distinguished inventor based in Singapore, SG, known for his significant contribution to the field of infectious and inflammatory diseases. With a strong focus on enhancing patient care through innovative evaluation methods, Larbi has made strides in the medical research community.

Latest Patents

Anis Larbi holds a notable patent titled "Method of evaluating progression of an infectious disease and/or inflammatory disease." This innovative method enables the evaluation of the risk of severe outcomes in patients with infectious or inflammatory diseases. By measuring the number of specific immune cells, such as VD2 T cells, CD8 T cells, and immature neutrophils from a patient sample, the method provides critical insights. Specifically, it identifies patients at enhanced risk based on established cellular ratios, which can guide treatment decisions. The patent also encompasses methods for treating patients facing severe outcomes and includes a comprehensive kit for practical application.

Career Highlights

Anis Larbi is currently contributing his expertise at the Agency for Science, Technology and Research. His work combines scientific rigor with a practical approach to addressing complex health issues. His patent underscores his commitment to furthering understanding in the realm of infectious diseases, making his work pivotal within the healthcare community.

Collaborations

Throughout his career, Anis has collaborated with esteemed colleagues such as Guillaume Robert Carissimo and Immanuel Kwok Weng Han. These partnerships have been instrumental in enhancing the scope and impact of his research in evaluating and treating infectious and inflammatory diseases.

Conclusion

Anis Larbi exemplifies the innovative spirit necessary to advance medical science. His patent represents a crucial step in improving patient outcomes for those suffering from severe infectious and inflammatory diseases. With ongoing collaborations and a robust career, Larbi continues to pave the way for future advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…